ArticleOncoTargets and therapy2020

Complete Response to the Sequential Treatment with Regorafenib Followed by PD-1 Inhibitor in a Sorafenib-Refractory Hepatocellular Carcinoma Patient.

Er-Lei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.